Inhibitor Therapeutics (INTI) Common Equity (2012 - 2026)
Inhibitor Therapeutics (INTI) recorded Common Equity of -$2.56 million in Q2 2026, compared with $715,637 a year earlier.
Powered by 
Analysis
Inhibitor Therapeutics (INTI) Common Equity (2012 - 2026) Analysis & Trends
At the end of FY2025, Inhibitor Therapeutics reported Common Equity of -$1.29 million.
- Across earlier years, Common Equity came in at $1.99 million in FY2024 (-62.4%), $5.28 million in FY2023 (-36.3%), $8.3 million in FY2022 and -$3.62 million in FY2021.
- The Q2 2026 figure is the lowest quarterly Common Equity since Q3 2022.
- The year-over-year decline in Common Equity has ranged between 36.3% (Q4 2023) and 99.9% (Q3 2025) over the last five years.
- Per Business Quant, the preceding three quarters came in at -$1.98 million (Q1 2026), -$1.29 million (Q4 2025) and $3,453 (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Common Equity (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn | 84.97 Bn |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn | -5.94 Bn |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn | 41.98 Bn |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn | 41.95 Bn |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn | 50.37 Bn |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn | 11.69 Bn |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn | 11.83 Bn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 85.49 Bn |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn | 20.25 Bn |
| 10 | Inhibitor Therapeutics | 17.38 Mn | 17.38 Mn | - | -2.56 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -2.56 Mn |
| Mar 31, 2026 | -1.98 Mn |
| Dec 31, 2025 | -1.29 Mn |
| Sep 30, 2025 | 3,453.00 |
| Jun 30, 2025 | 715,637.00 |
| Mar 31, 2025 | 1.35 Mn |
| Dec 31, 2024 | 1.99 Mn |
| Sep 30, 2024 | 3.41 Mn |
| Jun 30, 2024 | 4.14 Mn |
| Mar 31, 2024 | 4.64 Mn |
| Dec 31, 2023 | 5.28 Mn |
| Sep 30, 2023 | 6.45 Mn |
| Jun 30, 2023 | 7.11 Mn |
| Mar 31, 2023 | 7.76 Mn |
| Dec 31, 2022 | 8.30 Mn |
| Sep 30, 2022 | -4.02 Mn |
| Jun 30, 2022 | -3.90 Mn |
| Mar 31, 2022 | -3.77 Mn |
| Dec 31, 2021 | -3.62 Mn |
| Sep 30, 2021 | -3.54 Mn |
API Access
Inhibitor Therapeutics Common Equity API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=common-equity&ticker=INTI&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "common-equity", "ticker": "INTI", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=common-equity&ticker=INTI&period=max&api_key=YOUR_API_KEY");
const data = await res.json();